Funders · Entity Annotation Prototype (beta)

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: UK Medicines and Healthcare products Regulatory Agency ×

UK Medicines and Healthcare products Regulatory Agency

This funder is selected. Its supporting articles are shown below.

UK Medicines and Healthcare products Regulatory Agency2

Articles mentioning UK Medicines and Healthcare products Regulatory Agency

2 articles · page 1 of 1

Protocol for a phase I single-centre dose escalation trial of autologous thymus derived regulatory T cells in paediatric heart transplant recipients to prevent cardiac allograft vasculopathy (ATT-Heart)

bmjopen · abstract · 2026-05-21 · 1 matching annotations

86.5%

UK Medicines and Healthcare products Regulatory Agency Great Ormond Street Hospital TR006 Cardiac allograft vasculopathy (CAV)immunosuppression autologous thymus-derived Treg cell therapy

…rence: 24/SC/0333). Clinical trials authorisation approval from UK Medicines and Healthcare products Regulatory Agency has also been received. The clinical trial will be conducted in…

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol

bmjopen · abstract · 2026-01-27 · 1 matching annotations

84.5%

UK Medicines and Healthcare products Regulatory Agency Berkshire Research Ethics Committee Salmonella enterica Typhi Enteric fever Serum Institute of India Salmonella enterica Paratyphi A paratyphoid A typhoid S. Paratyphi A S. Typhi+1 more